Macroglossia
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Biomarker for Maroteaux-Lamy Disease (BioMaroteaux) (NCT01458613) | CENTOGENE GmbH Rostock | 2018-08-20 |
| Biomarker for Pompe Disease (BioPompe) (NCT01457443) | CENTOGENE GmbH Rostock | 2018-08-20 |
| S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis (NCT03499808) | SWOG Cancer Research Network | 2018-06-06 |
Track Macroglossia automatically
Every clearance here is in the API, with alerts when new ones post.